Medical guidelines governing extravasation management in the Netherlands outline strict protocols for treating accidental leaks of vesicant chemotherapy drugs outside the blood vessel. The updated recommendations advise against subcutaneous or topical corticosteroid injections following vesicant extravasation, citing evidence linking these treatments to a higher incidence of surgical interventions for resulting skin defects. Instead, clinical standards point toward specific enzymatic interventions and restrict treatments that risk exacerbating tissue damage.
Risks of Corticosteroid Use in Vesicant Extravasations
The application of intradermal corticosteroids for treating extravasations remains strictly limited under current clinical insights. A key study highlights that administering subcutaneous corticosteroid injections after the extravasation of blistering chemotherapy drugs correlates with an increased rate of operations required to address skin defects.
When an intravenously administered medication inadvertently enters the surrounding tissue rather than the blood vessel, the resulting damage depends heavily on the specific drug involved. Vesicants are notorious for causing severe local tissue destruction, blistering, and necrosis if allowed to pool in the subcutaneous space.
Hyaluronidase Protocols for Grade 3 and Grade 4 Extravasations
For severe extravasations, clinicians may apply hyaluronidase to limit localized destruction. Hyaluronidase functions by breaking down hyaluronic acid in connective and epithelial tissue, thereby dissolving subcutaneous tissue barriers. This enzymatic breakdown allows the extravasated fluid to disperse over a broader surface area where it undergoes rapid dilution by extracellular fluids.
National guidelines recommend hyaluronidase for grade 4 extravasation, with symptoms including:
- Severe localized pain
- Pronounced swelling
- Tissue pallor
- Blister formation
- Necrosis
For grade 3 extravasations, physicians may consider the enzyme depending on clinical presentation. Grade 3 events typically feature a painful injection site, moderate swelling, and blanching of the affected tissue area.
Exceptions for Sympathicomimetics and Vasopressor Extravasations
Certain classes of medications require entirely different management strategies. For extravasations involving sympathicomimetics and other specific vasoconstrictive agents, hyaluronidase is contraindicated regardless of injury severity.
Multidisciplinary Development of Extravasation Guidelines
The comprehensive protocol governing these interventions was established through an initiative by the Dutch Association of Hospital Pharmacists (NVZA). The guideline was developed at the initiative of the NVZA, in collaboration with plastic surgeons (NVPC), nurse practitioners (V&VN), pediatricians (NVK), and patient representatives (Patiëntenfederatie Nederland), including:
- Dutch Association for Plastic Surgery (NVPC)
- Nurse Specialists Netherlands (V&VN)
- Dutch Association of Paediatrics (NVK)
- Patient Federation Netherlands (Patiëntenfederation Nederland)
This coordinated framework standardizes the response to chemotherapy and drug leaks across Dutch healthcare institutions, prioritizing targeted enzymatic dilution over unverified topical or subcutaneous steroid therapies.
Worth a look